(Date:7/25/2008)...n cause immune system changes , , FRIDAY...inking gastroesophageal reflux disease (GERD) and ...cal Center researchers. , An association betwee... and since then studies have shown that between 50...perience GERD symptoms. But the actual link betwee...
(Date:7/25/2008)...ivers immediate cost savings for http://www.lle-i...guage interpreters] to firms switching language p... Washington, D.C. (Vocus) Jul.../index.html [(Language Learning Enterprises, Inc....ion, and language instruction services to thousand...
(Date:7/25/2008)... an Olympian, Professional Athlete, Elite Amateur ... to Know about Hydration to Boost Sports Performan... Marina del Rey, Calif. (Voc...e heading to Beijing following years of intense tr... capturing an Olympic medal and securing their pla...
(Date:7/25/2008)...ill be used to facilitate the planning and designi... Hauppauge, NY (PRWEB) July 25,...tegrator of enterprise collaboration solutions inc...sence, audio visual integration, and managed confe...ted video conferencing equipment to Mt. Sinai,s Ch...
Breaking Medicine News(10 mins):Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2(Date:7/24/2008)...ce, July 24 /- NicOx S.A.,(...results from the 52-week,open label safety extensi...the 301 phase 3 study for naproxcinod. The results...cy was maintained for the one-year duration of,the...ment scale. In,addition, the results showed that t...
(Date:7/23/2008)...swire/ -- FluoroPharma Inc., a company developing,...tron Emission Tomography,(PET) market, announced p...ine-18 labeled tracer for myocardial perfusion ima...r product to complete Phase I clinical,development...ss the blood flow in the,heart (myocardial perfusi...
(Date:7/22/2008)...uly 22 /- Following a,thoro...d of Progen,Pharmaceuticals Limited (ASX: PGL; Nas...d the PI-88 phase 3 study in liver cancer. Progen ...xisting portfolio of compounds and,the company wil...d,opportunities through Merger & Acquisition activ...
(Date:7/22/2008)...ibility and Efficacy of Treating Patients with ...RANCISCO, and YONGIN-SI, South Korea, July 22 /PRN...Ottawa, Ontario), and its South,Korean partner Gre...s from,a Phase I clinical trial of its first-in-cl...uct was well-tolerated and resulted in clear,anti-...
Breaking Medicine Technology:NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Childrens HeartLink 28R 29 to Benefit From Sales of Kim 26 Scotts Gourmet Pretzels 28R 29 Valentines Day Love Knot Sampler 28TM 29 10034 1Childrens HeartLink 28R 29 to Benefit From Sales of Kim 26 Scotts Gourmet Pretzels 28R 29 Valentines Day Love Knot Sampler 28TM 29 10034 2Thalidomide Pharmion 28R 29 Receives Positive Opinion for Treatment of First line Multiple Myeloma from European Medicines Agency 1267 1Thalidomide Pharmion 28R 29 Receives Positive Opinion for Treatment of First line Multiple Myeloma from European Medicines Agency 1267 2Thalidomide Pharmion 28R 29 Receives Positive Opinion for Treatment of First line Multiple Myeloma from European Medicines Agency 1267 3Thalidomide Pharmion 28R 29 Receives Positive Opinion for Treatment of First line Multiple Myeloma from European Medicines Agency 1267 4Thalidomide Pharmion 28R 29 Receives Positive Opinion for Treatment of First line Multiple Myeloma from European Medicines Agency 1267 5Thalidomide Pharmion 28R 29 Receives Positive Opinion for Treatment of First line Multiple Myeloma from European Medicines Agency 1267 6Stem Cells Finally Found in Pancreas 10027 1Stem Cells Finally Found in Pancreas 10027 2Stem Cells Finally Found in Pancreas 10027 3The Great Safety Adventure 28R 29 Traveling Home Safety Exhibit Kicks Off Tenth Anniversary Tour 10023 1The Great Safety Adventure 28R 29 Traveling Home Safety Exhibit Kicks Off Tenth Anniversary Tour 10023 2The Great Safety Adventure 28R 29 Traveling Home Safety Exhibit Kicks Off Tenth Anniversary Tour 10023 3...ompany to Proceed with Development Program for Ora...DGE, Mass.--(BUSINESS WIRE)--July 2, 2007--Alkerme...eliminary results from a,clinical trial of ALKS 29...ults, the company plans to move forward with its,d...treat alcohol,dependence. ALKS 29 is a combination...
...NVER--(BUSINESS WIRE)--Jul 2, 2007 - Ceragenix Pha...al company focused on,infectious disease and derma...iversity of Pennsylvania led by Dr. Paul,Janmey an... B.,Savage of Brigham Young University, have demon...n investigational drug compound known,as CSA-13 sh...
Other Medicine Technology:Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 2Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 3Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 4...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: